Go Pro

BioVie (BIVIW) Competitors

BioVie logo
$0.53 +0.03 (+5.80%)
As of 07/16/2026 02:12 PM Eastern
This is a fair market value price provided by Massive. Learn more.

BIVIW vs. SXTPW, DRTSW, APLMW, CDIOW, and CELUW

Should you buy BioVie stock or one of its competitors? MarketBeat compares BioVie with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with BioVie include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), Cardio Diagnostics (CDIOW), and Celularity (CELUW). These companies are all part of the "biotechnology" industry.

How does BioVie compare to 60 Degrees Pharmaceuticals?

BioVie (NASDAQ:BIVIW) and 60 Degrees Pharmaceuticals (NASDAQ:SXTPW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, analyst recommendations, risk, profitability, institutional ownership, media sentiment, valuation and earnings.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A

In the previous week, BioVie and BioVie both had 1 articles in the media. BioVie's average media sentiment score of 1.89 beat 60 Degrees Pharmaceuticals' score of 0.94 indicating that BioVie is being referred to more favorably in the media.

Company Overall Sentiment
BioVie Very Positive
60 Degrees Pharmaceuticals Positive

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
60 Degrees Pharmaceuticals N/A N/A N/A

Summary

BioVie and 60 Degrees Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

How does BioVie compare to Alpha Tau Medical?

Alpha Tau Medical (NASDAQ:DRTSW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, risk, media sentiment, institutional ownership, earnings and profitability.

In the previous week, Alpha Tau Medical and Alpha Tau Medical both had 1 articles in the media. BioVie's average media sentiment score of 1.89 beat Alpha Tau Medical's score of 1.87 indicating that BioVie is being referred to more favorably in the news media.

Company Overall Sentiment
Alpha Tau Medical Very Positive
BioVie Very Positive

Company Net Margins Return on Equity Return on Assets
Alpha Tau MedicalN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Alpha Tau MedicalN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

BioVie beats Alpha Tau Medical on 1 of the 1 factors compared between the two stocks.

How does BioVie compare to Apollomics?

Apollomics (NASDAQ:APLMW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, analyst recommendations, institutional ownership, earnings, valuation, dividends, profitability and media sentiment.

In the previous week, Apollomics and Apollomics both had 1 articles in the media. Apollomics' average media sentiment score of 1.89 equaled BioVie'saverage media sentiment score.

Company Overall Sentiment
Apollomics Very Positive
BioVie Very Positive

Company Net Margins Return on Equity Return on Assets
ApollomicsN/A N/A N/A
BioVie N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Apollomics$8.50MN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

Apollomics beats BioVie on 1 of the 1 factors compared between the two stocks.

How does BioVie compare to Cardio Diagnostics?

BioVie (NASDAQ:BIVIW) and Cardio Diagnostics (NASDAQ:CDIOW) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their profitability, media sentiment, institutional ownership, earnings, risk, analyst recommendations, valuation and dividends.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Cardio Diagnostics$16.57KN/AN/AN/AN/A

In the previous week, BioVie and BioVie both had 1 articles in the media. BioVie's average media sentiment score of 1.89 beat Cardio Diagnostics' score of 1.87 indicating that BioVie is being referred to more favorably in the media.

Company Overall Sentiment
BioVie Very Positive
Cardio Diagnostics Very Positive

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Cardio Diagnostics N/A N/A N/A

Summary

BioVie and Cardio Diagnostics tied by winning 1 of the 2 factors compared between the two stocks.

How does BioVie compare to Celularity?

BioVie (NASDAQ:BIVIW) and Celularity (NASDAQ:CELUW) are both medical companies, but which is the superior investment? We will contrast the two businesses based on the strength of their profitability, valuation, dividends, earnings, risk, media sentiment, analyst recommendations and institutional ownership.

Company Net Margins Return on Equity Return on Assets
BioVieN/A N/A N/A
Celularity N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BioVieN/AN/AN/AN/AN/A
Celularity$26.55MN/AN/AN/AN/A

In the previous week, BioVie and BioVie both had 1 articles in the media. BioVie's average media sentiment score of 1.89 equaled Celularity'saverage media sentiment score.

Company Overall Sentiment
BioVie Very Positive
Celularity Very Positive

Summary

Celularity beats BioVie on 1 of the 1 factors compared between the two stocks.

Get BioVie News Delivered to You Automatically

Sign up to receive the latest news and ratings for BIVIW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

BIVIW vs. The Competition

MetricBioVieBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$525.31M$6.96B$12.67B
Dividend YieldN/A3.90%2.68%8.87%
P/E RatioN/A3.1427.1824.05
Price / SalesN/A6,485.30577.75112.08
Price / CashN/A13.1349.2559.89
Price / BookN/A87.9210.786.23
Net IncomeN/A-$96.07M$3.59B$331.94M
7 Day Performance-3.64%-1.81%-1.92%-1.65%
1 Month Performance60.30%1.35%2.24%-1.03%
1 Year PerformanceN/A55.00%23.85%17.10%

BioVie Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
BIVIW
BioVie
N/A$0.53
+5.8%
N/AN/A$0.00N/AN/AN/A
SXTPW
60 Degrees Pharmaceuticals
N/A$0.02
-0.4%
N/AN/A$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.66
-5.2%
N/A+991.2%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.01
-4.2%
N/A-47.0%$0.00$8.50MN/A59
CDIOW
Cardio Diagnostics
N/A$0.02
-14.9%
N/A+1.3%$0.00$16.57KN/A7

Related Companies and Tools


This page (NASDAQ:BIVIW) was last updated on 7/17/2026 by MarketBeat.com Staff.
From Our Partners